Yazar "Saglam S." için listeleme
-
Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study
Saglam S.; Bugra D.; Saglam E.K.; Asoglu O.; Balik E.; Yamaner S.; Bulut T. (Pioneer Bioscience Publishing, 2014)Background and purpose: The optimum duration between neoadjuvant radiochemotherapy and transmesorectal excision in locally advanced rectal cancer has not been defined yet. This randomized study was designed to compare the ... -
Neoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: Phase II study
Saglam S.; Arifoglu A.; Saglam E.K.; Tunca F.; Asoglu O.; Engin G.; Yamaner S. (Pioneer Bioscience Publishing, 2013)Purpose: Concomitant use of chemotherapy and a radiation dose schedule that is more efficient compared to conventional radiotherapy may provide better outcomes in patients with esophageal cancer. This study aimed to assess ... -
Robotic versus laparoscopic surgery for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of short-term outcomes
Serin K.R.; Gultekin F.A.; Batman B.; Ay S.; Kapran Y.; Saglam S.; Asoglu O. (Springer-Verlag London Ltd, 2015)The aim of our study was to compare short-term outcomes of robotic and laparoscopic sphincter-saving total mesorectal excision (TME) in male patients with mid-low rectal cancer (RC) after neadjuvant chemoradiotherapy (NCRT). ...